Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Basilea Pharmaceutica Ltd (BPMUF)
Market Closed
18 Jun, 20:00
OTC PINK
All
(6)
DE
(2)
CH
(1)
GB
(2)
US
(1)
SIX
Primary
LSE
OTC PINK
XSTU
XDUS
CBOE
$
60.
27
0
0%
$
846.88M
Market Cap
7.96
P/E Ratio
20%
Div Yield
12
Volume
2.9
Eps
$
60.27
Previous Close
Watching
Watch
Add Transaction
Day Range
60.27
60.27
Year Range
57.7
74
Want to track
BPMUF
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Basilea Pharmaceutica Ltd (BPMUF) Statistics
Valuation metrics
Market Cap
846.88M
Enterprise value
694.5M
Trailing P/E (ttm)
19.36
Forward P/E
-
PEG ratio
-0.35
Price/Sales (ttm)
3.52
Price/Book (mrq)
4.89
Enterprise Value/Revenue
3.85
Enterprise Value/EBITDA
16.57
Overview
Shares outstanding
12.29M
Float
12.21M
Shares short
-
% Held by insiders
0.01%
% Held by institutions
0.3%
Average volume (10 days)
14
Average volume (90 days)
6
Price summary
52-Week low
57.7
52-Week high
74
Beta
0.42
50-Day moving average
65.37
200-Day moving average
68.01
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
21 Jun 2013
Ex-Dividend Date
11 Apr 2013
Last split factor
1,039:1,029
Last split Date
13 Mar 2007
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.18%
Operating margin
0.22%
Operational effectiveness
Return on assets
0.11%
Return on equity
0.28%
Income Statement
Revenue (ttm)
294.12M
Revenue per share (ttm)
14.78
Quarterly revenue growth (yoy)
-0.03%
Gross profit (ttm)
110.32M
EBITDA
51.05M
Net income to common (ttm)
50.93M
Diluted EPS (ttm)
2.65
Quarterly earnings growth (yoy)
-0.57%
Balance Sheet
Total cash (mrq)
202.25M
Total cash per share (mrq)
13.3
Total debt (mrq)
112.92M
Total Debt/Equity (mrq)
0.7
Current ratio (mrq)
5.11%
Book value per share (mrq)
10.48
Cash Flow
Cash flow statement
78.59M
Levered free cash flow (LFCF)
62.22M